Chewelah Orthopedic & Sports Physical Therapy Inc. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: N 119 3rd St E, Chewelah, WA 99109 Phone: 509-935-4988 Fax: 509-935-4985 |
Paul Michael Cockerham, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 N. Park St., Chewelah, WA 99109 Phone: 509-935-4988 |
Robert Ray Brewer, PT, MOMT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: N. 119 3rd St. E., Chewelah, WA 99109 Phone: 509-935-4988 Fax: 509-935-4985 |
News Archive
SafeMinds sees a brighter future after the implementation of long-overdue EPA regulation of hazardous air pollution from coal-fired power plants. Less mercury means its potent neurotoxic effects are less likely to harm childhood development.
In the wake of the tragedy at the Boston Marathon, Aetna has opened its student and employee assistance program lines for any person who may be having difficulty coping with this senseless act of violence.
A new study using a pig model of cystic fibrosis (CF) suggests that low levels of a growth promoting hormone at or before birth may contribute to growth defects in patients with CF.
Aurora BayCare Medical Center in Green Bay, Wisconsin, is the first U.S. hospital to be verified as an Emergency Center of Excellence(TM) by Emergency Excellence (EmEx), a company specializing in emergency department benchmarking. At the annual meeting of the American College of Emergency Physicians in Boston, Emergency Excellence recognized Aurora BayCare Medical Center's dedication to excellent emergency care. EmEx developed the award in response to the 2006 Institute of Medicine's call for emergency medicine improvement and to motivate emergency care providers to achieve a higher standard of quality.
Daiichi Sankyo Company, Ltd. (hereinafter Daiichi Sankyo) and Ambit Biosciences, jointly announced today that they have entered into a definitive merger agreement under which Daiichi Sankyo will acquire all of the outstanding common stock of Ambit Biosciences for $15 per share in cash through a tender offer followed by a merger with a subsidiary of Daiichi Sankyo, or approximately $315 million on a fully diluted basis.
› Verified 8 days ago